🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Prerna Singh

University of Maryland, Baltimore

ORCID: 0000-0002-7808-6049

Also affiliated with Georgetown University, Homi Bhabha National Institute, Georgetown University Medical Center, Tata Memorial Hospital, Bristol-Myers Squibb (United States), Advanced Centre for Treatment, Research and Education in Cancer, U-M Rogel Cancer Center

MedicineNeuroscience

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “PP2A-activating Drugs Enhance FLT3 Inhibitor Efficacy through AKT Inhibition–Dependent GSK-3β–Mediated c-Myc and Pim-1 Proteasomal Degradation”.

PP2A-activating Drugs Enhance FLT3 Inhibitor Efficacy through AKT Inhibition–Dependent GSK-3β–Mediated c-Myc and Pim-1 Proteasomal Degradation

Molecular Cancer Therapeutics(2021)10.1158/1535-7163.mct-20-0663
N/A
0DataRank · unranked
26 citations

Prerna Singh, Christopher M. Bailey, Jonelle K. Lee, Shivani Kapoor, Rena G. Lapidus +7 more

Pim kinase inhibitor co-treatment decreases alternative non-homologous end-joining DNA repair and genomic instability induced by topoisomerase 2 inhibitors in cells with FLT3 internal tandem duplication

Oncotarget(2021)10.18632/oncotarget.28042
N/A
0DataRank · unranked
3 citations

Shivani Kapoor, Eric S. Tvedte, Kshama A. Doshi, Ying Zou, Prerna Singh +8 more

Exploring the role of casein kinase 1α splice variants across cancer cell lines

Biochemical and Biophysical Research Communications(2024)10.1016/j.bbrc.2024.150189
N/A
0DataRank · unranked
1 citations

Daniel T. Wynn, Siva Bharath Merugu, Prerna Singh, Kenton P. Kaplan, David J. Robbins +1 more